Description
Generic Version of Carfilzomib Available in India?
Carfilzomib is the generic name of the medication and is its international nonproprietary name. Carfilzomib is marketed under the brand name Carzomib among others.
Carfilzomib, is an anti-cancer medication acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.
The FDA approved carfilzomib in July 2012, for use in people with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy (such as lenalidomide) and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Will this product be accessible across all regions of India?
The product – Carzomib (Carfilzomib) Injection will be available across India on request. Carfilzomib is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
References
- Dr Reddy’s to market three Amgen drugs in India.
- Amgen gets cosier with Dr. Reddy’s, adding three marketed drugs to Indian partnership.
- Dr. Reddy’s to Market and Distribute Amgen’s RepathaTM (evolocumab), Kyprolis® (carfilzomib) and BLINCYTO® (blinatumomab) in India upon Approval